Abstract: To obtain a brake fluid pressure control device for a saddle-type vehicle capable of improving airtightness between a main body portion and a lid of a housing, suppressing a sealing material from leaking to the outside of the brake fluid pressure control device, and having a smaller size than the conventional one.

Abstract: A hydraulic pressure control unit capable of suppressing application of an external force thereto in comparison with the related art at the time when mounted to a straddle-type vehicle is obtained. A hydraulic pressure control unit (1) includes: a base body (10) formed with an internal channel through which a brake fluid flows; and a housing (40) that is connected to the base body (10) and accommodates a circuit board. A dimension in a width direction (Y) of the housing (40) is greater than a dimension in the width direction (Y) of the base body (10). In a state where the hydraulic pressure control unit (1) is seen in a connection direction (X), a center in the width direction (Y) of the base body (10) is located on a first side surface (45) side from a center in the width direction (Y) of the housing (40).

Abstract: To obtain a hydraulic pressure control unit that can be downsized. A hydraulic pressure control unit (1) for a brake system mounted to a straddle-type vehicle includes: a coil unit (60) used to open/close a channel of a brake fluid; a housing (40) that accommodates the coil unit (60); a placement table (90) held by the housing (40); and a base body (10) having an upper surface (18) to which the coil unit (60) and the housing (40) are connected. The placement table (90) is configured that at least a part thereof is arranged below a portion of a coil housing (65) of the coil unit (60) and that, in a state before the coil unit (60) and the housing (40) are connected to the base body (10), a support section (91) supports the portion of the coil housing (65) from below.

Abstract: A hydraulic pressure control unit (1) for a brake system mounted to a straddle-type vehicle includes a housing (40) that accommodates a circuit board (31). The housing (40) includes: a main body (41) formed with an opening (43a) in a region opposing the circuit board (31); a lid (48) that covers the opening (43a) and adheres to the main body (41); and a lid fixing section (50) provided in a space surrounded by the main body (41) and the lid (48) and fixing the lid (48) to the main body (41). The lid fixing section (50) includes: an engaged section (51) held by one of the main body (41) and the lid (48); and an engaging section (55) that is held by the other of the main body (41) and the lid (48) and engages with the engaged section (51).

Abstract: A balloon catheter includes a shaft and a balloon having one or more fold lines. The balloon is disposed outside the shaft, and the balloon includes one or more first regions and one or more second regions. The first region retains medicine on an outer surface of the balloon. The second region retains less medicine than the first region or retains no medicine.

Abstract: A balloon catheter includes a shaft, and a balloon provided outside the shaft. A drug is provided on an outer surface of the balloon, and the balloon has at least a straight tube part. A change ratio of an outer diameter of the straight tube part, (D28?D24)/D24, is 1.1% or less. D24 is the outer diameter of the straight tube part when an internal pressure of 2.43 MPa (24 atm) is applied, and D28 is the outer diameter of the straight tube part when an internal pressure of 2.84 MPa (28 atm) is applied.

Abstract: A method for recycling a used balloon catheter includes accepting a used balloon catheter. The balloon catheter includes a detector that detects a state value including at least a pressure generated in a pipe path formed within the balloon catheter and a storage that stores a result of detection of the state value by the detector. The method includes determining at least one of reusability of the used balloon catheter and a method of recycling the used balloon catheter, based on the result of detection stored in the storage of the used balloon catheter.

Abstract: A balloon catheter includes a shaft and a balloon having one or more fold lines. The balloon is disposed outside the shaft, and the balloon includes one or more first regions and one or more second regions. The first region retains medicine on an outer surface of the balloon. The second region retains less medicine than the first region or retains no medicine.

Abstract: A balloon catheter includes a shaft, and a balloon provided outside the shaft. A drug is provided on an outer surface of the balloon, and the balloon has at least a straight tube part. A change ratio of an outer diameter of the straight tube part, (D28?D24)/D24, is 1.1% or less. D24 is the outer diameter of the straight tube part when an internal pressure of 2.43 MPa (24 atm) is applied, and D28 is the outer diameter of the straight tube part when an internal pressure of 2.84 MPa (28 atm) is applied.

Abstract: To provide an injector for ophthalmology which can guide an implant easily to an transplant place without causing any damage to the implant when the implant is inserted into an eyeball. The injector for an eye used for inserting an implant into an eyeball comprises an outer tube, and an implant holding structure arranged in the outer tube to be slidable with respect to the outer tube. The implant holding structure has an implant holding portion which can be contained in the outer tube and forms a space for containing the implant between the implant holding portion and the inner surface of the outer tube when it is contained in the outer tube. The implant holding portion projects from the outer tube when the implant holding structure is advanced and the implant can be taken out from the outer tube.

Abstract: [PROBLEMS] To provide an injector for ophthalmology which can guide an implant easily to an transplant place without causing any damage to the implant when the implant is inserted into an eyeball. [MEANS FOR SOLVING PROBLEMS] The injector for an eye used for inserting an implant into an eyeball comprises an outer tube, and an implant holding structure arranged in the outer tube to be slidable with respect to the outer tube. The implant holding structure has an implant holding portion which can be contained in the outer tube and forms a space for containing the implant between the implant holding portion and the inner surface of the outer tube when it is contained in the outer tube. The implant holding portion projects from the outer tube when the implant holding structure is advanced and the implant can be taken out from the outer tube.

Abstract: A tube device for insertion into a lacrimal passage, optimized according to the structure of a lacrimal passage and capable of being operated without impairing the functional effect of a lacrimal passage endoscope. A tube device for insertion into a lacrimal passage comprises a pair of tubes to be placed in the lacrimal passage. Openings are formed at both ends of the pair of tubes. A reinforcement body is disposed and held in the vicinity of each opening at a position located at a predetermined distance from the opening.

Abstract: It is intended to provide a stent to be placed in the living body which exhibits excellent extension properties even in a flexion site of a lumen in the body and shows a low restenosis rate after being placed in the living body.

Abstract: It is intended to provide a stent to be placed in the living body which exhibits excellent extension properties even in a flexion site of a lumen in the body and shows a low restenosis rate after being placed in the living body.

Abstract: [PROBLEMS] To provide an injector for ophthalmology which can guide an implant easily to an transplant place without causing any damage to the implant when the implant is inserted into an eyeball. [MEANS FOR SOLVING PROBLEMS] The injector for an eye used for inserting an implant into an eyeball comprises an outer tube, and an implant holding structure arranged in the outer tube to be slidable with respect to the outer tube. The implant holding structure has an implant holding portion which can be contained in the outer tube and forms a space for containing the implant between the implant holding portion and the inner surface of the outer tube when it is contained in the outer tube. The implant holding portion projects from the outer tube when the implant holding structure is advanced and the implant can be taken out from the outer tube.

Abstract: It is intended to proved a stent to be placed in the living body which shows a low restenosis rate after being placed in the body. A stent to be placed in the living body characterized in that the stent is in a long and thin almost tubular shape having both termini and provided with voids, the long and thin almost tubular body can be extended in the radial direction from the first diameter in the compressed state to be second diameter in the extended state, the strut section of the stent is in an almost square or rectangular shape, the whole surface of the stent has an outer surface, an inner surface and a side surface area corresponding to the area of the side surface is not more than 40% of the whole surface area corresponding to the area of the whole surface of the stent.

Abstract: It is intended to easily provide a stent for placement in body which can hold an increased amount of a drug without causing cracking or peeling in the coating layer with the dilation of the stent and from which the drug can be sustainedly released as far as possible. Namely, a stent for placement in body having a coating layer mainly comprising a drug and a polymer in at least a part of the stent surface wherein the coating layer consists of an inner layer and an outer layer, the weight ratio of drug/polymer, which is defined based on the weights of the drug and the polymer contained in each layer, of the inner layer is higher than that of the outer layer, and the outer layer contains an efficacious amount of the drug.

Abstract: It is intended to provide a stent to be used in a lumen which can uniformly cover an intralumen tissue, relieve troubles (for example, restenosis) in the intralumen tissue upon stent dilation, by easily compressed and fixed to a balloon or the like and safely move forward in the oral cavity of a patient's body, on which a sufficient amount of a drag can be fixed and from which the drug can be uniformly released into the intralumen tissue. Namely, a stent to be used in a lumen characterized in that it can be dilated from a first diameter in the compressed state to a second diameter in the enlarged state and, in the state of the first diameter, struts constituting the stent overlap together in the radius direction at least in one part.

Abstract: As a treatment for angiostenosis, angioplasty (PTA or PTCA) of expanding a small-sized balloon in a vessel has been commonly conducted. However, this treatment easily causes repeated stenosis (restenosis) after the treatment. Placement of a stent in a vessel is also effective in decreasing restenosis, but this treatment may also cause restenosis. The present invention provides a stent containing a poly (lactide-co-glycolide) or both a poly (lactide-co-glycolide) and an immunosuppressive agent in at least a portion of a surface of the stent, and further containing a material nondegradable in vivo.